Interpretable machine learning uncovers epithelial transcriptional rewiring and a role for Gelsolin in COPD.

Journal: JCI insight
PMID:

Abstract

Transcriptomic analyses have advanced the understanding of complex disease pathophysiology including chronic obstructive pulmonary disease (COPD). However, identifying relevant biologic causative factors has been limited by the integration of high dimensionality data. COPD is characterized by lung destruction and inflammation, with smoke exposure being a major risk factor. To define previously unknown biological mechanisms in COPD, we utilized unsupervised and supervised interpretable machine learning analyses of single-cell RNA-Seq data from the mouse smoke-exposure model to identify significant latent factors (context-specific coexpression modules) impacting pathophysiology. The machine learning transcriptomic signatures coupled to protein networks uncovered a reduction in network complexity and new biological alterations in actin-associated gelsolin (GSN), which was transcriptionally linked to disease state. GSN was altered in airway epithelial cells in the mouse model and in human COPD. GSN was increased in plasma from patients with COPD, and smoke exposure resulted in enhanced GSN release from airway cells from patients with COPD. This method provides insights into rewiring of transcriptional networks that are associated with COPD pathogenesis and provides a translational analytical platform for other diseases.

Authors

  • Justin Sui
    Division of Pulmonary, Allergy and Critical Care Medicine.
  • Hanxi Xiao
    Center for Systems Immunology, Departments of Immunology and Computational & Systems Biology, University of Pittsburgh, Pittsburgh, PA, USA.
  • Ugonna Mbaekwe
    Division of Pulmonary, Allergy and Critical Care Medicine.
  • Nai-Chun Ting
    Division of Pulmonary, Allergy and Critical Care Medicine.
  • Kaley Murday
    Division of Pulmonary, Allergy and Critical Care Medicine.
  • Qianjiang Hu
    Division of Pulmonary, Allergy and Critical Care Medicine.
  • Alyssa D Gregory
    Division of Pulmonary, Allergy and Critical Care Medicine.
  • Theodore S Kapellos
    Institute of Lung Health and Immunity, Comprehensive Pneumology Center (CPC), Helmholtz Zentrum München, Member of the German Center for Lung Research (DZL), Munich, Germany.
  • Ali Öender Yildirim
    Institute of Lung Health and Immunity, Comprehensive Pneumology Center (CPC), Helmholtz Zentrum München, Member of the German Center for Lung Research (DZL), Munich, Germany.
  • Melanie Königshoff
    Division of Pulmonary, Allergy, and Critical Care Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania.
  • Yingze Zhang
    Division of Pulmonary, Allergy and Critical Care Medicine.
  • Frank Sciurba
    Department of Medicine, University of Pittsburgh Medical Center, Pittsburgh, PA, 15213, USA.
  • Jishnu Das
    Center for Systems Immunology, Departments of Immunology and Computational & Systems Biology, University of Pittsburgh, Pittsburgh, PA, USA. jishnu@pitt.edu.
  • Corrine R Kliment
    Division of Pulmonary, Allergy and Critical Care Medicine.